You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study
|
---|---|
Published in |
European Journal of Preventive Cardiology, February 2011
|
DOI | 10.1177/1741826710389391 |
Pubmed ID | |
Authors |
Anders G Olsson, Christina Lindahl, Ingar Holme, Rana Fayyad, Ole Faergeman, John J P Kastelein, Matti J Tikkanen, Mogens Lytken Larsen, Terje R Pedersen, the Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group |
Abstract |
We assessed the proportion of patients treated with either simvastatin 20 or 40 mg or atorvastatin 80 mg who achieved low-density lipoprotein cholesterol (LDL-C) goals of 2.5 or 2.0 mmol/l in the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) study. We explored how lipoprotein components related to cardiovascular disease (CVD) outcomes in these groups. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 3% |
United States | 1 | 3% |
Unknown | 29 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 23% |
Student > Ph. D. Student | 6 | 19% |
Student > Master | 4 | 13% |
Student > Postgraduate | 3 | 10% |
Other | 2 | 6% |
Other | 5 | 16% |
Unknown | 4 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 48% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 2 | 6% |
Nursing and Health Professions | 2 | 6% |
Business, Management and Accounting | 1 | 3% |
Other | 2 | 6% |
Unknown | 7 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2013.
All research outputs
#17,289,387
of 25,377,790 outputs
Outputs from European Journal of Preventive Cardiology
#2,105
of 2,806 outputs
Outputs of similar age
#154,955
of 194,724 outputs
Outputs of similar age from European Journal of Preventive Cardiology
#28
of 38 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,806 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.9. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,724 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.